ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
2 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
Tuhorangi
|
901 |
280K |
13 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
901
|
280K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
21 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Tuhorangi
|
184 |
65K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
184
|
65K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
39 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Tuhorangi
|
273 |
118K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
273
|
118K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
17 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Tuhorangi
|
551 |
203K |
11 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
551
|
203K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Tuhorangi
|
551 |
203K |
16 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
203K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
8 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Taken up the entitlement?
|
|
Tuhorangi
|
544 |
131K |
4 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
544
|
131K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Information For Retail Shareholders
|
|
Tuhorangi
|
541 |
115K |
10 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
541
|
115K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
FDA does not over-rule positive ODAC decisions
|
|
Tuhorangi
|
161 |
78K |
2 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
161
|
78K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Tuhorangi
|
1.0K |
386K |
9 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
1.0K
|
386K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP
|
|
Tuhorangi
|
144 |
66K |
27 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
66K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
4 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
GVHD the first step
|
|
Tuhorangi
|
239 |
65K |
6 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
239
|
65K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Ceasing to be a substantial holder
|
|
Tuhorangi
|
8 |
3.9K |
2 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
8
|
3.9K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
3 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
9.6K
|
2.8M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
Tuhorangi
|
321 |
103K |
2 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
321
|
103K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
whispers of gamestop style short squeeze incoming IM ON are u?
|
|
Tuhorangi
|
90 |
32K |
5 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
90
|
32K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
Tuhorangi
|
537 |
241K |
4 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
537
|
241K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
rurenga
|
|
Tuhorangi
|
62 |
22K |
10 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
62
|
22K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Tuhorangi
|
880 |
213K |
6 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
880
|
213K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Tuhorangi
|
1.0K |
326K |
18 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
1.0K
|
326K
|
18
|
|
ASX - By Stock
|
ADO |
Re:
Moving forward
|
|
Tuhorangi
|
88 |
27K |
4 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
88
|
27K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
Tuhorangi
|
451 |
114K |
1 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
451
|
114K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB - A Question of Trust?
|
|
Tuhorangi
|
297 |
70K |
2 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
297
|
70K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Tuhorangi
|
10K |
3.0M |
4 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Tuhorangi
|
4.7K |
1.1M |
5 |
12/09/21 |
12/09/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Tuhorangi
|
4.7K |
1.1M |
23 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
Tuhorangi
|
206 |
62K |
2 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
206
|
62K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Tuhorangi
|
4.7K |
1.1M |
1 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
Tuhorangi
|
1.5K |
501K |
4 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
1.5K
|
501K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Tuhorangi
|
10K |
3.0M |
2 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
Tuhorangi
|
1.5K |
412K |
2 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
1.5K
|
412K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
Tuhorangi
|
1.5K |
412K |
2 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
1.5K
|
412K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
Tuhorangi
|
1.5K |
412K |
0 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
1.5K
|
412K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
Tuhorangi
|
1.5K |
412K |
2 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
1.5K
|
412K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian Newspaper MSB trial failure
|
|
Tuhorangi
|
255 |
70K |
8 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
255
|
70K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Tuhorangi
|
9.6K |
2.8M |
5 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
9.6K
|
2.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
Tuhorangi
|
300 |
85K |
11 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
300
|
85K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
Tuhorangi
|
300 |
85K |
6 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
300
|
85K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
Tuhorangi
|
300 |
85K |
3 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
300
|
85K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Tuhorangi
|
10K |
3.0M |
1 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - Quarterly, Strong Commercialization Revenues
|
|
Tuhorangi
|
299 |
98K |
3 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
299
|
98K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Tuhorangi
|
10K |
3.0M |
3 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|